GLYATL2
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| glycine-N-acyltransferase like 2 | MIM:614762 | Ensembl:ENSG00000156689 | HGNC:HGNC:24178 | PA142671728 | 11q12.1 |
GO terms in GLYATL2
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IDA | GO:0047961 | glycine N-acyltransferase activity |
| BP | IDA | GO:0042758 | long-chain fatty acid catabolic process |
| BP | IDA | GO:0051793 | medium-chain fatty acid catabolic process |
| BP | IDA | GO:1903965 | monounsaturated fatty acid catabolic process |
| CC | IEA | GO:0005739 | mitochondrion |
| CC | IDA | GO:0005783 | endoplasmic reticulum |
Gene expression in normal tissue: GLYATL2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GLYATL2
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP521 | Amino acid conjugation of benzoic acid |
| wikipathways | WP702 | Metapathway biotransformation Phase I and II |
| reactome | R-HSA-1430728 | Metabolism |
| reactome | R-HSA-156580 | Phase II - Conjugation of compounds |
| reactome | R-HSA-156587 | Amino Acid conjugation |
| reactome | R-HSA-159424 | Conjugation of carboxylic acids |
| reactome | R-HSA-177128 | Conjugation of salicylate with glycine |
| reactome | R-HSA-177135 | Conjugation of benzoate with glycine |
| reactome | R-HSA-211859 | Biological oxidations |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD494 | Neopeltolide | 3 |
| iGMDRD781 | Sirolimus | 1 |
| iGMDRD387 | CHIR-99021 | 3 |
| iGMDRD5 | Tyrphostin AG 1478 | 3 |
| iGMDRD138 | PX 12 | 3 |
| iGMDRD505 | Pevonedistat | 3 |
| iGMDRD506 | Fedratinib | 3 |
| iGMDRD780 | PP-30 | 3 |
| iGMDRD286 | Nsc 632839 | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in GLYATL2

